EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Electrochemically Engineered GQDs for Selective Tumor Targeting and Oxidative Nanotherapy in Triple-Negative Breast Cancer

Mohammad Suhaan Dar iD, Niroj Kumar Sahu iD

ACS Omega · 20.01.2026 · 11 (2) · 3354-3367

DOI: 10.1021/acsomega.5c10310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 02.01.2026. Verfasst von Mohammad Suhaan Dar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Nanotechnology Research, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu 632014, India. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Centre for Nanotechnology Research, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu 632014, India.
  • School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu 632014, India.

ORCID-Profile: Mohammad Suhaan Dar, Niroj Kumar Sahu

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Dar, M. S., & Sahu, N. K. (2026). Electrochemically Engineered GQDs for Selective Tumor Targeting and Oxidative Nanotherapy in Triple-Negative Breast Cancer. ACS Omega, 11(2), 3354-3367. https://doi.org/10.1021/acsomega.5c10310

Vancouver

Dar MS, Sahu NK. Electrochemically Engineered GQDs for Selective Tumor Targeting and Oxidative Nanotherapy in Triple-Negative Breast Cancer. ACS Omega. 2026;11(2):3354-3367. doi:10.1021/acsomega.5c10310

BibTeX
@article{Dar2026,
  author = {Dar, Mohammad Suhaan and Sahu, Niroj Kumar},
  title = {Electrochemically Engineered GQDs for Selective Tumor Targeting and Oxidative Nanotherapy in Triple-Negative Breast Cancer},
  journal = {ACS Omega},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {3354--3367},
  doi = {10.1021/acsomega.5c10310}
}
Kostenlos starten →